| Sign In to gain access to subscriptions and/or personal tools. |
Neuroleptic malignant syndrome due to three atypical antipsychotics in a childDivision of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul National University Bundang Hospital, Seoul, Korea.
Division of Child and Adolescent Psychiatry, Department of psychiatry, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea.
Division of Child and Adolescent Psychiatry, Department of psychiatry, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea., soochurl{at}snu.ac.kr Neuroleptic Malignant Syndrome (NMS) is a rare, potentially fatal and idiosyncratic drug reaction. It is characterized by a sudden loss of body temperature control, renal and respiratory failure, muscle rigidity, loss of consciousness and impairment of autonomic nervous system. Although NMS was previously associated with the use of classical high-potency neuroleptics, cases have started to emerge with atypical neuroleptics. This article discusses the first case of NMS in a child, induced by the use of risperidone, olanzapine and quetiapine.
Key Words: neuroleptic malignant syndrome risperidone olanzapine quetiapine
Journal of Psychopharmacology, Vol. 19, No. 4,
422-425 (2005) |
|||